Cargando…

Osteoporosis Drug Treatment Update

The Brazilian population is aging and the prevalence of chronic degenerative diseases, including osteoporosis, is increasing. The diagnosis and treatment of osteoporosis have made significant advances in the last decade. The orthopedist and traumatologist can no longer be detained only in the surgic...

Descripción completa

Detalles Bibliográficos
Autores principales: Oliveira, Lindomar Guimarães, Carneiro, Mara Lúcia Rassi Guimarães, Souza, Márcio Passini Gonçalves de, Souza, Caio Gonçalves de, Moraes, Frederico Barra de, Camargo, Fábio Lopes de
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Thieme Revinter Publicações Ltda. 2021
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8558937/
https://www.ncbi.nlm.nih.gov/pubmed/34733425
http://dx.doi.org/10.1055/s-0040-1714219
Descripción
Sumario:The Brazilian population is aging and the prevalence of chronic degenerative diseases, including osteoporosis, is increasing. The diagnosis and treatment of osteoporosis have made significant advances in the last decade. The orthopedist and traumatologist can no longer be detained only in the surgical treatment of osteoporotic fracture. It is extremely important that we know: 1) what risk factors to evaluate, and the Fracture Risk Assesment Tool (FRAX) can be used; 2) which complementary tests should be requested, such as densitometry, radiography of the spine and pelvis, blood and urine tests, and even bone biopsy; 3) which supplements to use, such as calcium and magnesium, vitamins D and K; 4) which medications to prescribe, antiresorptives or trainers, therapeutic windows and adverse events.